Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MannKind Corp MNKD

Healthcare Biotechnology
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung where they can exert an effect locally or enter the... see more

Recent & Breaking News (NDAQ:MNKD)

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against MannKind Corp. - MNKD

Business Wire January 15, 2016

Insider Alert: Here's Why These Small Caps Could Be Ready To Bounce...

Accesswire January 13, 2016

MannKind Provides Update on Senior Management

GlobeNewswire January 11, 2016

INVESTOR ALERT: Goldberg Law PC Announces An Investigation of Claims against MannKind Corp. And Encourages Investors With Losses In Excess of $250,000 To Contact The Firm

Business Wire January 8, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud by MannKind Corp. and Certain Officers and Directors

Business Wire January 8, 2016

INVESTOR NOTICE: Khang & Khang LLP Announces an Ongoing Investigation of Claims against MannKind Corp. and Advises Investors with Losses in Excess of $250,000 to Contact the Firm

Business Wire January 7, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of MannKind Corp. (MNKD)

PR Newswire January 7, 2016

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Claims Against MannKind Corp. and Advises Investors to Contact the Firm

Business Wire January 6, 2016

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against MannKind Corp. - MNKD

Business Wire January 6, 2016

MannKind Corporation Announces Termination of License and Collaboration Agreement With Sanofi

GlobeNewswire January 5, 2016

MannKind Corporation to Present at the J.P. Morgan 2016 Healthcare Conference

Press Releases December 29, 2015

MannKind Announces Appointment of Duane DeSisto as Chief Executive Officer

GlobeNewswire December 23, 2015

Where We Are Headed -- Featured Research on Amicus Therapeutics, EP Energy, Knowles Corp, and Mannkind

Accesswire December 22, 2015

Factors Moving Markets - Free Research on Mannkind, Blue Buffalo Pet Products, Sanchez Energy, and Lumber Liquidators

Accesswire December 10, 2015

MannKind Announces Senior Management Changes

GlobeNewswire November 20, 2015

MannKind Announces Pricing of Registered Direct Offering

GlobeNewswire November 12, 2015

MannKind Confirms Planned Stock Sale

GlobeNewswire November 11, 2015

MannKind Corporation Reports 2015 Third Quarter Financial Results

GlobeNewswire November 9, 2015

MannKind Corporation to Hold 2015 Third Quarter Financial Results Conference Call on November 9, 2015

GlobeNewswire November 2, 2015

MannKind Announces Termination of Stock Lending Agreement

GlobeNewswire October 26, 2015